参考文献/References:
[1] Bliss M.Rewriting medical history:Charles Best and the Banting and Best myth[J].J Hist Med Allied Sci,1993,48(3):253-274.DOI:10.1093/jhmas/48.3.253.
[2] 西娅·库珀,亚瑟·恩斯伯格.突破胰岛素发现创造的医学奇迹.谢琨,译.上海:上海人民出版社,2011.
[3] Fralick M,Zinman B.The discovery of insulin in Toronto:beginning a 100 year journey of research and clinical achievement[J].Diabetologia,2021,64(5):947-953.DOI:10.1007/s00125-020-05371-6.
[4] Brownlee M.The pathobiology of diabetic complications:a unifying mechanism[J].Diabetes,2005,54(6):1615-1625.DOI:10.2337/diabetes.
[5] Kahn BB.Adipose tissue,inter-organ communication,and the path to type 2 diabetes:the 2016 Banting medal for Sscientifific achievement lecture[J].Diabetes,2019,68(1):3-14.DOI:10.2337/dbi18-0035.
[6] Colberg-Ochs SR.From froot loops to fitness:my journey as an educator and person with diabetes[J].Diabetes Spectr,2017,30(1):58-63.DOI:10.2337/ds16-0079.
[7] Yu MG,Keenan HA,Shah HS,et al.Residual β cell function and monogenic variants in long-duration type 1 diabetes patients[J].J Clin Invest,2019,129(8):3252-3263.DOI:10.1172/JCI127397.
[8] Sanger F,Thompson EO,Kitai R.The amide groups of insulin[J].Biochem J,1955,59(3):509-518.DOI:10.1042/bj0590509.
[9] Nicol DS,Smith LF.Amino-acid sequence of human insulin[J].Nature,1960,187:483-485.DOI:10.1038/187483a0.
[10] Yalow RS,Berson SA.Immunoassay of endogenous plasma insulin in man[J].J Clin Invest,1960,39(7):1157-1175.DOI:10.1172/JCI104130.
[11] Cohen SN,Chang AC,Boyer HW,et al.Construction of biologically functional bacterial plasmids in vitro[J].Proc Natl Acad Sci U S A,1973,70(11):3240-3244.DOI:10.1073/pnas.70.11.3240.
[12] Goeddel DV,Kleid DG,Bolivar F,et al.Expression in Escherichia coli of chemically synthesized genes for human insulin[J].Proc Natl Acad Sci USA,1979,76(1):106-110.DOI:10.1073/pnas.76.1.106.
[13] Rosenstock J,Bajaj HS,Janezˇ A,et al,Once-weekly insulin for type 2 diabetes without previous insulin treatment[J].N Engl J Med,2020,383(22):2107-2116.DOI:10.1056/NEJMoa2022474.
[14] Kjeldsen TB,Hubálek F,Hjørringgaard CU,et al.Molecular engineering of insulin icodec,the first acylated insulin analog for once-weekly administration in humans[J].J Med Chem,2021,64(13):8942-8950.DOI:10.1021/acs.jmedchem.1c00257.
[15] Kurtzhals P,Schäffer L,Sørensen A,et al.Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use[J].Diabetes,2000,49(6):999-1005.DOI:10.2337/diabetes.49.6.999.
[16] Barnett AH,Bellary S.Inhaled human insulin(Exubera):clinical profile and patient considerations[J].Vasc Health Risk Manag,2007,3(1):83-91.
[17] Klonoff DC.Afrezza inhaled insulin:the fastest-acting FDA-approved insulin on the market has favorable properties[J].J Diabetes Sci Technol,2014,8(6):1071-1073.DOI:10.1177/1932296814555820.
[18] Eldor R,Arbit E,Corcos A,et al.Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes:a pilot study[J].PLoS One,2013,8(4):e59524.DOI:10.1371/journal.pone.0059524.
[19] Wong CY,Al-Salami H,Dass CR.Microparticles,microcapsules and microspheres:a review of recent developments and prospects for oral delivery of insulin[J].Int J Pharm,2018,537(1-2):223-244.DOI:10.1016/j.ijpharm.2017.12.036.
[20] Yu J,Wang J,Zhang Y,et al.Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs[J].Nat Biomed Eng,2020,4(5):499-506.DOI:10.1038/s41551-019-0508-y.
[21] Elsherif M,Hassan MU,Yetisen AK,et al.Glucose sensing with phenylboronic acid functionalized hydrogel-based optical diffusers[J].ACS Nano,2018,12(3):2283-2291.DOI:10.1021/acsnano.7b07082.